INS and diabetes mellitus: After adjusting for age, gender, ethnicity, diabetes duration, HbA1c, BMI, insulin treatment, number of anti-hypertensives, history of PVD, and baseline eGFR (R2 0.87), baseline foot insensitivity was associated with study-end eGFR (B = −3.551, p = 0.036) (Table 4).